-
The RSA Group reveals new global brand
Jun 5, 2020, 09:40 AM by Michael CroftLONDON, UK - Jun 5, 2020 - The RSA Group, the leading global specialist in Life Sciences Executive Search, is excited to share its new global brand and websiteFull story -
COVID-19 Update: Structural Modeling, New Funding, Vaccine News
Jun 5, 2020, 08:20 AM by Michael CroftBio-IT World | More updates on SARS-CoV-2 research and COVID-19 from the Bio-IT Community including an app to create COVID-19 severity scores, new insights into viral behavior, modeling tools for the virus structure, and an influx of funding from Illumina, the Department of Defense, AstraZeneca, and more.Full story -
BOC Sciences Offers Raw Chemical Materials for Manufacturing Test Kits and Vaccines
Jun 4, 2020, 22:35 PM by Michael CroftSHIRLEY, NY - Jun 5, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical raw material supplier, announced to offer raw chemical materials needed for the manufacture of test kits and vaccines to meet the challenges facing the global pharmaceutical industry during the coronavirus outbreakFull story -
10x Genomics: Culture of Collaboration And A New Product Engine
Jun 4, 2020, 10:45 AM by Michael CroftFull storyBio-IT World | At 10x Genomics—where the vision is to “master biology”—culture is key.
-
Lyniate Facilitates Interoperability Ecosystem via Strategic Partnerships
Jun 3, 2020, 09:45 AM by Michael CroftBOSTON, MA, UNITED STATES - Jun 3, 2020 - Boston, MA - June 3, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced that as part of its effort to create a truly interoperable ecosystem in healthcare, it has partnered with two healthcare technology vendors: BioIntelliSense and HICGFull story -
Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX
Jun 2, 2020, 11:47 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Jun 2, 2020 - Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-upFull story -
InSysBio to announce the launch of QSP model of COVID-19
Jun 2, 2020, 10:21 AM by Michael CroftMOSCOW, RUSSIA - Jun 2, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19Full story -
UCB and N-SIDE increase their strategic collaboration
Jun 2, 2020, 05:11 AM by Michael CroftLOUVAIN-LA-NEUVE, BELGIUM - Jun 2, 2020 - N-SIDE, provider of innovative software and strategic consulting services, announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimizationFull story -
Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman
Jun 2, 2020, 04:47 AM by Michael CroftCAMBRIDGE, UK - Jun 2, 2020 - Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex LtdFull story -
MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform
Jun 2, 2020, 02:44 AM by Michael CroftHAIFA, ISRAEL - Jun 2, 2020 - MeMed Ltd., a leader in host response-based solutions, today announced that it has received a CE Mark in Europe for use of its diagnostic test MeMed BV and point-of-need platform MeMed KeyFull story -
Almac Clinical Technologies Introduces Simplify™, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up
Jun 1, 2020, 13:55 PM by Michael CroftSOUDERTON, PA, UNITED STATES - Jun 1, 2020 - Almac Clinical Technologies, part of the Almac Group, today announced the availability of SimplifyTM, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiencyFull story -
Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations
Jun 1, 2020, 12:43 PM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Jun 1, 2020 - PHILADELPHIA, PA (June 1, 2020) – Imvax, Inc., a clinical-stage biotechnology company, today announced that Iphigenia (Effie) Leonidou Koumenis has been appointed as Head of Clinical OperationsFull story -
Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer
Jun 1, 2020, 11:46 AM by Michael CroftNOTTINGHAM, UNITED KINGDOM - Jun 1, 2020 - Albumedix Ltd. (Albumedix), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020Full story -
Accumen Launches Hospital Lab Crisis Preparedness Program
May 29, 2020, 11:10 AM by Michael CroftPHOENIX, AZ - May 29, 2020 - Accumen Inc. is helping healthcare get better, faster. As an extension of its ongoing effort to provide resources that enable hospitals to manage every phase of the COVID-19 pandemic optimally, today Accumen launched its Lab Crisis Preparedness Program to help hospitals ensure their laboratories are able to meet the testing needs of their health system and surrounding communitiesFull story -
Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint®
May 29, 2020, 08:27 AM by Michael CroftIRVINE, CALIF., U.S., AND AMSTERDAM, NETHERLANDS - May 29, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced new data from MINDACT, the prospective randomized trial designed to further demonstrate the clinical utility of MammaPrint® risk scoring when determining a breast cancer patients need for chemotherapyFull story -
Shivom Launches FREE Informatics – Secure Health Data Sharing Solutions to Organisations Studying COVID-19.
May 29, 2020, 07:54 AM by Michael CroftLONDON, UNITED KINGDOM - May 29, 2020 - Shivom Ventures Limited Shivom today announced the startup will be playing its part in combating the deadly coronavirus disease by offering researchers and pharmaceutical companies a 1-year free subscription to interrogate both viral and human genomes separately from RAW sequencing dataFull story -
Studies Suggest COVID-19 Could Become Seasonal Virus, Other News
May 29, 2020, 07:25 AM by Michael CroftFull storyBio-IT World | A review of coronavirus immunity studies suggest the COVID-19 virus could become the fifth seasonal coronavirus with recurring epidemics of lessening severity over the next several years. Over 200 SARS-CoV-2 genome sequences have now been completed and released. We round up the week’s research and industry news for COVID-19.
-
BOC Sciences Adds Featured SARS-CoV-2 Inhibitors for Drug Discovery
May 28, 2020, 22:44 PM by Michael CroftSHIRLEY, NY, UNITED STATES - May 29, 2020 - In recent days, BOC Sciences, one of the world’s leading chemical and pharmaceutical provider, announced to add more than 100 inhibitors of SARS-CoV-2 to its present inhibitor base to help the drug discovery of scientific research institutions during the COVID-19 pandemicFull story -
Elucid Digital Health reduces smart Pill Connect bottle to a smart cap dispenser which can fit on any medicine bottle
May 28, 2020, 12:46 PM by Michael CroftMANCHESTER, UNITED KINGDOM - May 28, 2020 -Full story- The Elucid Digital Health screw on dispenser cap + app prompts compliance, messages patients, records temperature and humidity and provides real time reports for doctors or monitors
- Compliance in clinical trials is a serious problem with patients failing to comply - deteriorating as the trial progresses
- Non-compliance is estimated by the OECD to cause 200,000 premature deaths in Europe and estimated to cost E 125 billion in EU $105 billion in the US annually in avoidable hospitalisations, emergency care, and outpatient visitsx
-
CD Genomics Launches NGS Panels for SARS-CoV-2 Detection and Research
May 28, 2020, 10:26 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 20, 2020 - CD Genomics has developed a very comprehensive NGS panels for sequencing, coronaviruses detection, phylogenetic analysis and molecular characterization of the 2019 novel coronavirus (namely SARS-CoV-2, and the virus is responsible for COVID-19)Full story